Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Woman's Heart: The Microvascular Disease Dilemma.

The Canadian journal of cardiology·2026
Same author

Novel Use of Dual-Lumen Microcatheter for False Lumen Hematoma Decompression: Tools for Consideration.

JACC. Case reports·2026
Same author

Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.

The Canadian journal of cardiology·2026
Same author

A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.

The Canadian journal of cardiology·2026
Same author

Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.

The Canadian journal of cardiology·2026
Same author

Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention.

American heart journal·2025
Same journal

Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease.

The Canadian journal of cardiology·2026
Same journal

Storm Clouds Coming: Red-Flag Warning for Hypertension Prevalence and Control in the Post-COVID-19 Era.

The Canadian journal of cardiology·2026
Same journal

Universal coverage, unequal care: Why Canada needs a national cardiovascular access ledger.

The Canadian journal of cardiology·2026
Same journal

Prolonged Loop Recorder Retention: Safety, Diagnostic Yield, and the Case for Community-Based Explantation.

The Canadian journal of cardiology·2026
Same journal

Multimodality Fusion Imaging of Subclinical Systemic Right Ventricular Remodeling in Congenitally Corrected Transposition of the Great Arteries.

The Canadian journal of cardiology·2026
Same journal

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Stop the Invasion-Advances in Myocardial Revascularization.

Marc Ruel1, Aun Yeong Chong2, Alexa L Grudzinski3

  • 1Division of Cardiac of Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

The Canadian Journal of Cardiology
|May 20, 2026
PubMed
Summary
This summary is machine-generated.

Myocardial revascularization, using percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), has advanced significantly. Innovations enhance patient outcomes, focusing on minimally invasive techniques and collaborative care models for coronary disease management.

Keywords:
coronary artery bypass graft surgeryguideline-directed medical therapyminimally invasive surgerypercutaneous coronary interventionquality of life

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Experiment Videos

Last Updated: May 22, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Myocardial revascularization is crucial for managing acute and chronic coronary disease.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are key revascularization strategies.
  • Significant advancements have improved patient outcomes in coronary revascularization.

Purpose of the Study:

  • To review major milestones in myocardial revascularization.
  • To highlight Canadian contributions to coronary revascularization research.
  • To discuss the transition towards patient-centered, minimally invasive, and collaborative treatment models.

Main Methods:

  • Comprehensive review of advancements in PCI and CABG.
  • Analysis of innovations including drug-eluting stents, guided interventions, and transradial access.
  • Examination of surgical innovations like off-pump, minimally invasive, and robotic-assisted CABG.

Main Results:

  • PCI innovations enhance safety and durability, including drug-eluting stents and guided interventions.
  • CABG offers superior long-term survival for complex coronary disease.
  • Surgical advancements reduce trauma and improve recovery, with robotic assistance enabling less invasive approaches.

Conclusions:

  • Hybrid coronary revascularization combines CABG durability with PCI precision.
  • Future of coronary care involves patient-centered, minimally invasive, and collaborative multidisciplinary approaches.
  • Ongoing transitions aim to optimize revascularization strategies for improved patient outcomes.